Literature DB >> 16728343

Increasing expression of GST-pi MIF, and ID1 genes in chemoresistant prostate cancer cells.

D-S Yu1, D S Hsieh, S Y Chang.   

Abstract

The differential expression of genes and related proteins of multidrug resistance in chemoresistant prostate cancer cell lines were elucidated in this study. RNA extracted from doxorubicin-resistant rat prostate cancer (PCa) cells (AT3/ADR1000) and native PCa cells was hybridized to expression arrays containing cDNAs from 588 known genes. Differential expression of selected genes was confirmed by quantitative reverse-transcription polymerase chain reaction (RT-PCR) analysis. Protein contents were measured by fluorescent flow cytometry and immunoblotting. Localization of selected proteins in cells was observed by immunocytochemical staining. Up-regulation of eleven genes and down-regulation of one single gene were displayed in the chemoresistant prostate cancer cells. Overexpression of mRNAs in macrophage migration inhibitory factor (MIF), DNA binding protein inhibitor 1 (ID1), and glutathione S-transferase-pi (GST-pi) were confirmed by gene-specific RT-PCR. Protein over-expression of GST-pi, MIF, and ID1 in resistant cells were 3.3-, 1.5-, and 1.5-fold to native cells, respectively. Immunocytochemistry revealed that GST-pi, MIF, and ID1 were present primarily in the cytoplasm of tumor cells, but ID1 also could be found in the nucleus. AT3/ADR1000 drug-resistant PCa cells displayed significantly increased expression of GST-pi, MIF, and ID1 proteins when compared with native PCa cells. It indicates these genes may play a role in drug resistance of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728343     DOI: 10.1080/01485010600630124

Source DB:  PubMed          Journal:  Arch Androl        ISSN: 0148-5016


  8 in total

1.  Morphoproteomic confirmation of an activated nuclear factor-кBp65 pathway in follicular thyroid carcinoma.

Authors:  Jing Liu; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

2.  Macrophage migration inhibitory factor expression in cervical cancer.

Authors:  Mathias Krockenberger; Jörg B Engel; Julia Kolb; Yvonne Dombrowsky; Sebastian F M Häusler; Nico Kohrenhagen; Johannes Dietl; Jörg Wischhusen; Arnd Honig
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-14       Impact factor: 4.553

3.  Inhibitor of DNA binding-1 overexpression in prostate cancer: relevance to tumor differentiation.

Authors:  Xiaoling Yu; Xiaohui Xu; Baojian Han; Rongxiang Zhou
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

Review 4.  Glutathione S-Transferases in Cancer.

Authors:  Rahul Raj Singh; Katie M Reindl
Journal:  Antioxidants (Basel)       Date:  2021-04-29

5.  Environmental Toxicant Induced Epigenetic Transgenerational Inheritance of Prostate Pathology and Stromal-Epithelial Cell Epigenome and Transcriptome Alterations: Ancestral Origins of Prostate Disease.

Authors:  Rachel Klukovich; Eric Nilsson; Ingrid Sadler-Riggleman; Daniel Beck; Yeming Xie; Wei Yan; Michael K Skinner
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

6.  Arsenic-induced changes in the gene expression of lung epithelial L2 cells: implications in carcinogenesis.

Authors:  Tisha Posey; Tingting Weng; Zhongming Chen; Narendranath R Chintagari; Pengcheng Wang; Nili Jin; Heidi Stricker; Lin Liu
Journal:  BMC Genomics       Date:  2008-03-03       Impact factor: 3.969

7.  Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells.

Authors:  Seul-Ki Cheon; Hwang-Phill Kim; Ye-Lim Park; Jee-Eun Jang; Yoojoo Lim; Sang-Hyun Song; Sae-Won Han; Tae-You Kim
Journal:  Mol Oncol       Date:  2018-07-11       Impact factor: 6.603

8.  ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy.

Authors:  Jiao Meng; Kaiyi Liu; Yang Shao; Xu Feng; Zhaodong Ji; Bin Chang; Yan Wang; Ling Xu; Gong Yang
Journal:  Cell Death Dis       Date:  2020-02-20       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.